Search results
Keeler Thomas Management LLC Lowers Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoKeeler Thomas Management LLC trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC ...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
The Woonsocket Call· 5 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 3 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 5 days agoAmgen (NASDAQ:AMGN – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 7 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Harbor Advisory Corp MA Decreases Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 12 hours agoHarbor Advisory Corp MA lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 23 hours agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Johnson & Johnson (NYSE:JNJ) Stock Holdings Decreased by Mitchell Mcleod Pugh & Williams Inc.
ETF DAILY NEWS· 12 hours agoMitchell Mcleod Pugh & Williams Inc. decreased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 28,869 ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...